Review: taking Suboxone and Clindamycin phosphate together


Summary

Drug interactions are reported among people who take Suboxone and Clindamycin phosphate together. This review analyzes the effectiveness and drug interactions between Suboxone and Clindamycin phosphate. It is created by eHealthMe based on reports of 19 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Suboxone

Suboxone has active ingredients of buprenorphine hydrochloride; naloxone hydrochloride. It is often used in drug dependence. (latest outcomes from Suboxone 15,624 users)

Clindamycin Phosphate

Clindamycin phosphate has active ingredients of clindamycin phosphate. It is often used in acne. (latest outcomes from Clindamycin phosphate 1,588 users)

On Sep, 15, 2016

19 people who take Suboxone, Clindamycin Phosphate are studied.


Number of reports submitted per year:

Suboxone and Clindamycin phosphate drug interactions.

Drug effectiveness over time:

Suboxone:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 100.0% - (1 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Clindamycin Phosphate:
n/a

Drug effectiveness by gender:

Suboxone:
  • female: 100.0% - (1 of 1 people)
  • male: 0.0% - (0 of 0 people)
Clindamycin Phosphate:
n/a

Drug effectiveness by age:

Suboxone:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 100.0% - (1 of 1 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)
Clindamycin Phosphate:
n/a

Most common drug interactions over time *:

< 1 month:
  • chest pain
  • drug abuser
  • electrocardiogram qt prolonged
  • electrocardiogram st-t segment abnormal
  • electrocardiogram u-wave abnormality
1 - 6 months:
  • feeding disorder neonatal
  • foetal exposure during pregnancy
  • low birth weight baby
  • premature baby
  • respiratory disorder neonatal
  • breech presentation
6 - 12 months:
  • low birth weight baby
  • premature baby
  • respiratory disorder neonatal
  • attention deficit/hyperactivity disorder
  • breech presentation
  • hepatocellular injury
  • maternal drugs affecting foetus
  • restlessness
  • foetal exposure during pregnancy
  • feeding disorder neonatal
2 - 5 years:
  • anxiety
  • homicidal ideation
  • major depression
  • panic attack
  • post-traumatic stress disorder
  • suicide attempt
5 - 10 years:
  • acute hepatic failure
  • hepatic encephalopathy
not specified:
  • fatigue
  • hypoaesthesia
  • anxiety
  • chest pain
  • abdominal pain
  • animal bite
  • blood cholesterol increased
  • constipation
  • decreased interest
  • excoriation

Most common drug interactions by gender *:

female:
  • rash
  • acute hepatic failure
  • anxiety
  • hepatic encephalopathy
  • homicidal ideation
  • major depression
  • panic attack
  • post-traumatic stress disorder
  • suicide attempt
male:
  • fatigue
  • hypoaesthesia
  • chest pain
  • abdominal pain
  • animal bite
  • anxiety
  • blood cholesterol increased
  • constipation
  • decreased interest
  • excoriation

Most common drug interactions by age *:

0-1:
  • feeding disorder neonatal
  • foetal exposure during pregnancy
  • low birth weight baby
  • premature baby
  • respiratory disorder neonatal
  • breech presentation
20-29:
  • rash
  • acne
  • cheilitis
  • chest pain
  • drug abuser
  • dry mouth
  • electrocardiogram qt prolonged
  • electrocardiogram st-t segment abnormal
  • electrocardiogram u-wave abnormality
30-39:
  • attention deficit/hyperactivity disorder
  • foetal exposure during pregnancy
  • hepatocellular injury
  • maternal drugs affecting foetus
  • restlessness
  • screaming
  • weight decreased
  • acute hepatic failure
  • hepatic encephalopathy
40-49:
  • anxiety
  • abdominal pain
  • animal bite
  • blood cholesterol increased
  • chest pain
  • constipation
  • decreased interest
  • excoriation
  • fatigue
  • general physical health deterioration
50-59:
  • drug dependence
  • fatigue
  • hypoaesthesia
  • nausea
  • overdose
  • pre-existing condition improved
  • road traffic accident
  • stress
  • substance abuse
  • drug abuse

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Suboxone and Clindamycin phosphate?

Can you answer these questions?

More questions for: Suboxone, Clindamycin phosphate

You may be interested in these reviews

More reviews for: Suboxone, Clindamycin phosphate

On eHealthMe, Suboxone (buprenorphine hydrochloride; naloxone hydrochloride) is often used to treat drug dependence. Clindamycin phosphate (clindamycin phosphate) is often used to treat acne. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.